Abstract:Aims: To assess the prevalence of human papillomavirus (HPV) type-specific infections and its influence on prognosis and survival rate of cervical cancer patients treated with radiotherapy alone or in combination with chemotherapy or hyperthermotherapy or both.Materials and methods: During 1993 and 1994, 120 patients with cervical cancer were consecutively assigned into four therapeutic modalities. One hundred and eight formalin-fixed and paraffin-embedded tissue samples available at the time of this study were subjected to DNA extraction. The DNA was analysed for the presence of HPV and HPV type-specific infections with polymerase chain reaction. The experimental data were co-analysed with the follow-up data to evaluate prognosis and survival in relation to the HPV infection and treatment.Results: All samples were found to be positive for HPV; 32.40% (95% confidence interval 23.72-42.09) of samples were HPV 16 single positive, 16.67% (95% confidence interval 10.19-25.06) were HPV 58 single positive, 34.26% (95% confidence interval 25.4-44.01) were HPV 16/58 double positive and 16.67% (95% confidence interval 10.19-25.06) were positive for other HPV types. The 5-year survival rates were 88.89, 80.0, 67.57 and 61.11% in patients with HPV 58 single positive, HPV 16 single positive, HPV 16/58 double positive, and other HPV types, respectively (P = 0.18), irrespective of the treatment modalities. Univariate Cox regression analysis results showed that compared with the HPV 16 single positive group, the relative risk of death was high in the HPV 16/58 double positive group (hazard ratio 1.81, 95% confidence interval 0.71-4.60) and the other HPV types group (hazard ratio 2.09, 95% confidence interval 0.73-5.96), whereas it was lower in the HPV 58 single positive group (hazard ratio 0.53, 95% confidence interval 0.11-2.56), but this was not statistically significant (P = 0.43). All results remained statistically non-significant after adjustment for age and tumour stage with multivariate Cox regression. No apparent differences were observed in the survival rates among the four groups with regard to the treatment protocols.Conclusion: No effect was seen of either treatment protocols or HPV type on survival, except for a slightly high survival in HPV 58 single-infected patients, which was statistically non-significant. Shah, W. et al. (2009). Clinical Oncology 21, 768-774 (C) 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

The Complex Relationship Between Human Papillomavirus and Cervical Adenocarcinoma

Prevalence of human papillomavirus infection in women with uterine cervical cancer in Wenzhou

The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China.

The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China.

Clinical Significance of Genotyping for Human Papillomavirus (HPV) 16 18/45 Combined with Cytology in Cervical Exfoliated Cells in HPV Oncogenic Mrna-Positive Women

Correlations between HPV16/18 infection and p16 expression in endocervical adeno carcinomas

Clustering Patterns of Type‐type Combination in Multiple Genotypes Infections of Human Papillomavirus in Cervical Adenocarcinoma

Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases

Clinicopathological Features and Outcomes in Different Histologic Subtypes of HPV-independent Endocervical Adenocarcinomas

Assessment of the relationships between invasive endocervical adenocarcinoma and human papillomavirus infection and distribution characteristics in China: According to the new WHO classification criteria in 2020

Prevalence and Frequencies of Human Papilloma Virus Types in Adenocarcinoma in Situ of the Uterine Cervix

Independent Validation of Distinct Clinicopathological Features and Prognosis among Usual-Type, Mucinous-Type and Gastric-Type Endocervical Adenocarcinoma Categorised by New WHO Classification (2020).

[Distribution of human papillomavirus genotypes in early-stadge cervical adenocarcinoma and its clinical significance].

No role for human papillomavirus in esophageal squamous cell carcinoma in China.

Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18

Distribution of Type-Specific Human Papillomavirus and Its Characters on Age in Paraffin-Embedded Adenocarcinoma Specimens

Single‐Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus‐Associated (HPVA) and Non‐HPVA Adenocarcinoma

Verification of HPV16 as a good prognostic factor for cervical adeno-adenosquamous carcinoma via an international collaborative study

The Prevalence of Human Papillomavirus Type 58 in Chinese Patients with Cervical Carcinoma and its Influence on Survival

Prevalence and Carcinogenic Risk of High-Risk Human Papillomavirus Subtypes in Different Cervical Cytology: a Study of 124,251 Cases from the Largest Academic Center in China.

[Association Between HPV DNA and Disease Specific Survival in Patients with Penile Cancer].